Human 3 with Brom and Sam
Episodes
$HIMS Q2 Results - our take as healthcare venture capitalists
05 Aug 2025
Contributed by Lukas
Brom Rector and Sam Tabone from XEIA Venture Partners - a VC firm that invests in the future of human health, wellbeing and performance - discuss $HIM...
Investing in Psychedelic BioTech [August 2025 webinar replay]
30 Jul 2025
Contributed by Lukas
Watch the video recording on YouTube: https://youtu.be/BM6x59oMnKg?si=qF0xDvgUMvU60ctP2025 has been the start of a bull period for psychedelic medicin...
Compass and ATAI latest news + are Psychedelics BACK in 2025?!
29 Jul 2025
Contributed by Lukas
The past few years have been rough for psychedelic and shroom stocks, but recent news from ATAI (and Recognify), Compass Pathways and GH Research + po...
Bryan Johnson's Neuralink competitor - with Kernel CEO Ryan Field
22 Jul 2025
Contributed by Lukas
Ryan Field is the CEO of Kernel, a brain-computer interface company founded by Bryan Johnson. Kernel is a cutting edge, non-invasive BCI that uses fNI...
How to start a VC fund
15 Jul 2025
Contributed by Lukas
I interviewed Michael Huseby to learn about his life story and his new book: Fundamentals: Your Friendly Guide to Investment Funds and SyndicationsThi...
Beyond Neuralink - Investing in Brain Computer Interfaces [webinar replay]
12 Jul 2025
Contributed by Lukas
Replay of our webinar on investing in brain computer interfaces. Join our upcoming July 30th event on investing in psychedelic biotech: psybio.org
Designing Novel Brain Drugs with Xylo Bio
08 Jul 2025
Contributed by Lukas
Xylo is a biotech startup that is using computational methods to design novel brain drugs to treat mental health disorders and neurodegeneration. Many...
The BioIndustrial Revolution: Why Peter Thiel and Chris Sacca backed Arye's Biomanufacturing Startup
30 Jun 2025
Contributed by Lukas
Arye Lipman is the cofounder of Biosphere, a startup that recently raised millions of dollars from Peter Thiel's Founders Fund and Chris Sacca's Lower...
Compass Pathways Phase 3 Psilocybin trial results - Psychedelic Stock down 50%?! Emergency podcast!
24 Jun 2025
Contributed by Lukas
Compass Pathways ($CMPS) released an interim readout from their Phase 3 trial of Psilocybin (COMP360) for treatment resistant depression (TRD). The da...
The genetic revolution in treating neurodegenerative disease with Martin Jacko
17 Jun 2025
Contributed by Lukas
Martin Jacko is the founder of Aperture Therapeutics, a startup developing ASO (Antisense Oligonucleotide) based therapies for neurodegenerative disea...
Brain implants without a hole in your skull - Wes Jones of Vonova
10 Jun 2025
Contributed by Lukas
Wes Jones is the CEO of Vonova, a brain computer interface company that (unlike Neuralink) is enabling access to the brain without drilling a hole in ...
The BioPunk Revolution with Elliot Roth
05 Jun 2025
Contributed by Lukas
Elliot Roth is the founder of the BioPunk community lab. He believes that biotech is broken and that "BioPunks" can fix it. Elliot sits down...
Can electricity cure brain cancer? Ben Woodington of Coherence Neuro on BCIs in oncology
27 May 2025
Contributed by Lukas
Ben Woodington is the cofounder and CEO of Coherence Neuro. Coherence's lead product, the SOMA-1, is a brain computer interface (BCI) that is designed...
Epigenetic Medicine with Laura Hsieh of TippingPoint Biosciences
22 May 2025
Contributed by Lukas
Laura Hsieh is the founder of TippingPoint Biosciences, an epigenetic medicine startup that has developed a breakthrough method of drugging the entire...
Top 10 Human 3 startups - brain implants, concierge longevity medicine, designer psychedelics and more
15 May 2025
Contributed by Lukas
Brom Rector and Sam Tabone from XEIA get specific on what Human 3 actually looks like in practice by analyzing 10 startups through the Human 3 lens.We...
Investing in Human 3 - the new epoch of health, wellbeing and performance
07 May 2025
Contributed by Lukas
Sam Tabone, Partner at XEIA joins Brom on the podcast to discuss XEIA's "Human 3" thesis.Check out XEIA at https://www.xeiavp.com/Timest...
SEAL Team 6 Veteran & TARA Mind Founder Marcus Capone on Psychedelic Therapy: from SEALS to Startups
19 Mar 2025
Contributed by Lukas
Marcus Capone is founder of TARA Mind. TARA Mind is an employee benefit provider that allows companies of all sizes to offer Ketamine therapy to their...
AI designed mRNA therapies: a Universal Toolkit for Genetic Medicine? Google-backed founder explains
28 Jan 2025
Contributed by Lukas
Amit Deshwar is the Founder & CTO of Kerna Labs. Backed by Gradient Ventures (Google's AI fund), Kerna Labs is building foundational AI models...
Project Stargate, AI agents, is Trump transitioning us from the Anthropocene to the Synthocene?
23 Jan 2025
Contributed by Lukas
Ramsay Brown, founder of Mission Control - a leading provider of AI agents / synthetic workers to the defense industry, joins us to discuss the end of...
Psychedelics and AI and in 2025 with Dillan DiNardo of Y Combinator-backed Mindstate Design Labs
17 Jan 2025
Contributed by Lukas
Dillan DiNardo, the founder and CEO of Mindstate Design Labs, a drug development company using AI to enable the precision design of altered states of ...
Making Deep Brain Stimulation Minimally Invasive with MJ Antonini and Nicki Driscoll of NeuroBionics
30 Sep 2024
Contributed by Lukas
Today’s guests are MJ Antonini & Nicki Driscoll, the founders of NeuroBionics, a neurotech startup out of MIT. NeuroBionics is making Deep Brain...
Using AI to uncover nature's hidden cures - Lars Wilde of Pangea Bio
08 Jul 2024
Contributed by Lukas
Lars Wilde is the cofounder of Pangea Bio - startup that uses AI to identify natural compounds and traditional remedies that may have medical applicat...
Advancements in Male Sexual Health w/ John Boghossian & Ryan Protzko of Kadence Bio
30 Apr 2024
Contributed by Lukas
Can a succulent plant from South Africa treat premature ejaculation? John Boghossian and Dr Ryan Protzko from Kadence Bio think so. www.kadencebio.c...
Can Skull Implants Treat Depression? Jacob Robinson & Motif Neurotech (Crossover Episode on Business Trip)
23 Oct 2023
Contributed by Lukas
Can brain implants treat your depression? Ok, technically this would be a skull implant, not a brain implant - but still! Jacob Robinson from Motif ...
Elliot Marseille - UC Berkeley Healthcare Economist on the Financial Viability of Psychedelic Therapy
06 Aug 2023
Contributed by Lukas
Will MDMA and psychedelic therapy be affordable? There are lots of questions about the economic and financial future of psychedelic therapies. How m...
Founder of the AI Responsibility Lab, Ramsay Brown on AI Safety, AI Coworkers & ChatGPT doing DMT
03 Mar 2023
Contributed by Lukas
🤖 ChatGPT & Dall-E today - misinformation, bias & worker displacement tomorrow. In a world where artificial intelligence is becoming increa...
Zach Haigney, Author of The Trip Report - Future Trends in Psychedelic Medicine
09 Jul 2022
Contributed by Lukas
Zach Haigney is the author of The Trip Report, a newsIetter that covers the emerging psychedelic science, medicine, and policy landscape. In this co...
Sam Banister - The Art and Science of Designing Novel Psychoactive Therapeutics
30 Jun 2022
Contributed by Lukas
Sam Banister is a medicinal chemist and co-founder of Psylo. Psylo is an Australian psychedelic biotech company using machine learning assisted ...
Music For Psychedelic Therapy - Mendel Kaelen, Founder and CEO of Wavepaths
08 May 2022
Contributed by Lukas
Mendel Kaelen is the CEO of Wavepaths. Prior to founding Wavepaths, Mendel Kaelen worked as a PhD and postdoctoral neuroscientist at Imperial Colleg...
Tom Feegel, CEO of Beond - Ending the Opiate Addiction Epidemic with Safe Ibogaine Treatment
27 Mar 2022
Contributed by Lukas
Tom Feegel is the Founder and CEO of Beond. Beond exists to help end the opiate addiction epidemic with safe ibogaine treatment. In this episode...
Dillan DiNardo - CEO of Mindstate Design Labs | Creating Novel Psychoactive Drugs at Y Combinator
10 Feb 2022
Contributed by Lukas
Dillan DiNardo is the CEO of Mindstate Design Labs - a preclinical-stage biotechnology company developing the next generation of psychedelic-inspired ...
27: Juan Pablo Cappello - CEO of Nue Life
09 Jan 2022
Contributed by Lukas
Mental health treatment is often inaccessible, inadequate, and ineffective. However, Nue Life is working to change this through its 360-degree approac...